Results Published From Small Clinical Trial of Adult Stem Cells in People with Relapsing MS

A team in Spain reports results from a small clinical trial involving 9 people with relapsing MS, using their own stem cells taken from their bone marrow, called mesenchymal stem cells, in a strategy aimed at inhibiting MS immune activity and augmenting natural tissue repair processes. The researchers reported finding no serious safety concerns or uptick in disease activity.

http://ift.tt/13dKCFx